PERINDOPRIL/AMLODIPINE-MEDIS 5/5 perindopril arginine 5 mg/amlodipine 5 mg tablet bottle

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

amlodipine besilate, Quantity: 6.94 mg; perindopril arginine, Quantity: 5 mg

Disponibbli minn:

Medis Pharma Pty Ltd

INN (Isem Internazzjonali):

amlodipine besilate,perindopril arginine

Għamla farmaċewtika:

Tablet

Kompożizzjoni:

Excipient Ingredients: crospovidone; trehalose dihydrate; light magnesium oxide; calcium hydrogen phosphate; sodium starch glycollate; magnesium stearate; microcrystalline cellulose; glycerol dibehenate

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

30

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

Perindopril/Amlodipine is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. Treatment should not be initiated with this combination.

Sommarju tal-prodott:

Visual Identification: white to off white, oval shaped tablet engraved with 5/5 on one face plain on the other face; Container Type: Bottle; Container Material: HDPE; Container Life Time: 6 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2015-08-07